182 related articles for article (PubMed ID: 19833318)
1. [Hemorrhagic risk of different perioperative anticoagulation protocols in patients implanted with a cardiac pacemaker or defibrillator: retrospective analysis in patients implanted in a community hospital].
Amara W; Ben Youssef I; Kamel J; Ghrissi I; Faron M; Khouadja A; Sergent J
Ann Cardiol Angeiol (Paris); 2009 Nov; 58(5):265-71. PubMed ID: 19833318
[TBL] [Abstract][Full Text] [Related]
2. Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators.
Robinson M; Healey JS; Eikelboom J; Schulman S; Morillo CA; Nair GM; Baranchuk A; Ribas S; Evans G; Connolly SJ; Turpie AG
Pacing Clin Electrophysiol; 2009 Mar; 32(3):378-82. PubMed ID: 19272069
[TBL] [Abstract][Full Text] [Related]
3. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD
Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702
[TBL] [Abstract][Full Text] [Related]
4. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
[TBL] [Abstract][Full Text] [Related]
5. Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios.
Ghanbari H; Feldman D; Schmidt M; Ottino J; Machado C; Akoum N; Wall TS; Daccarett M
Pacing Clin Electrophysiol; 2010 Apr; 33(4):400-6. PubMed ID: 20180915
[TBL] [Abstract][Full Text] [Related]
6. [Oral anticoagulation doesn't increase hemorrhagic risk in patients undergoing a cardiac pacemaker or defibrillator implantation].
Amara W; Ben Youssef I; Bonny A; Faron M; Monsel F; Sergent J
Ann Cardiol Angeiol (Paris); 2010 Nov; 59(5):255-9. PubMed ID: 20883977
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices.
Cano O; Muñoz B; Tejada D; Osca J; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A
Heart Rhythm; 2012 Mar; 9(3):361-7. PubMed ID: 22001709
[TBL] [Abstract][Full Text] [Related]
8. The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation.
Thal S; Moukabary T; Boyella R; Shanmugasundaram M; Pierce MK; Thai H; Goldman S
Pacing Clin Electrophysiol; 2010 Apr; 33(4):385-8. PubMed ID: 20059711
[TBL] [Abstract][Full Text] [Related]
9. Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.
Du L; Zhang Y; Wang W; Hou Y
Pacing Clin Electrophysiol; 2014 Nov; 37(11):1573-86. PubMed ID: 25234639
[TBL] [Abstract][Full Text] [Related]
10. Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patients.
Hammerstingl C; Omran H
Europace; 2011 Sep; 13(9):1304-10. PubMed ID: 21508005
[TBL] [Abstract][Full Text] [Related]
11. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals.
Jaffer AK; Brotman DJ; Bash LD; Mahmood SK; Lott B; White RH
Am J Med; 2010 Feb; 123(2):141-50. PubMed ID: 20103023
[TBL] [Abstract][Full Text] [Related]
12. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy.
Wiegand UK; LeJeune D; Boguschewski F; Bonnemeier H; Eberhardt F; Schunkert H; Bode F
Chest; 2004 Oct; 126(4):1177-86. PubMed ID: 15486380
[TBL] [Abstract][Full Text] [Related]
13. Perioperative anticoagulation for patients with mechanic heart valve(s) undertaking pacemaker implantation.
Cheng M; Hua W; Chen K; Pu J; Ren X; Zhao X; Liu Z; Wang F; Chen X; Zhang S
Europace; 2009 Sep; 11(9):1183-7. PubMed ID: 19666639
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices.
Korantzopoulos P; Letsas KP; Liu T; Fragakis N; Efremidis M; Goudevenos JA
Europace; 2011 Dec; 13(12):1669-80. PubMed ID: 21788280
[TBL] [Abstract][Full Text] [Related]
15. Systematic Implantation of Pacemaker/ICDs under Active Oral Anticoagulation Irrespective of Patient's Individual Preoperative Thromboembolic Risk.
Cano Ó; Andrés A; Jiménez R; Osca J; Alonso P; Rodríguez Y; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A; Martínez-Dolz L
Pacing Clin Electrophysiol; 2015 Jun; 38(6):723-30. PubMed ID: 25682988
[TBL] [Abstract][Full Text] [Related]
16. Risk of hematoma complications after device implant in the clopidogrel era.
Kutinsky IB; Jarandilla R; Jewett M; Haines DE
Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):312-8. PubMed ID: 20558847
[TBL] [Abstract][Full Text] [Related]
17. Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
Chen HC; Chen YL; Guo BF; Tsai TH; Chang JP; Pan KL; Lin YS; Chen MC
Can J Cardiol; 2013 Sep; 29(9):1110-7. PubMed ID: 23474139
[TBL] [Abstract][Full Text] [Related]
18. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review.
Carrel TP; Klingenmann W; Mohacsi PJ; Berdat P; Althaus U
J Heart Valve Dis; 1999 Jul; 8(4):392-8. PubMed ID: 10461238
[TBL] [Abstract][Full Text] [Related]
19. Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial.
Schulman S; Healey JS; Douketis JD; Delaney J; Morillo CA
Thromb Res; 2014 Oct; 134(4):814-8. PubMed ID: 25127655
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction.
Dotan ZA; Mor Y; Leibovitch I; Varon D; Golomb J; Duvdevani M; Ramon J
J Urol; 2002 Aug; 168(2):610-3; discussion 614. PubMed ID: 12131319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
